TNF, tumor necrosis factor, 7124

N. diseases: 2724; N. variants: 31
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis. 31818460 2020
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE The degree of secondary joint swelling and arthritis index, expression of miR-26a, pathological changes, proliferation and apoptosis of chondrocytes, and expression of CTGF, interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α, Bax, and Bcl-2 were also determined through a series of experiments. 31267533 2020
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE TNF-α: decreased in healthy, fatty liver, IBD and hepatic cirrhosis, no change in diabetes, metabolic syndrome (MS) + PCOS (polycystic ovary syndrome) and arthritis. 31060892 2020
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE Hence, the present study demonstrates that LPN-mediated TNF knockdown constitutes a promising approach for arthritis therapy of TNF-mediated chronic inflammatory conditions. 31199978 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE Diarylheptanoid, a constituent isolated from methanol extract of Alpinia officinarum attenuates TNF-α level in Freund's complete adjuvant-induced arthritis in rats. 30336303 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE These results suggest that TOV has significant anti-arthritic effects on collagen-induced arthritis in rats, which may be attributed to the inhibition of the levels of IL-1β, IL-6, IL-8, IL-17A, TNF-α, MMP-3 and MMP-9, and the increase of IL-10 in serum as well as down-regulation of the protein expression of COX-2 and iNOS in synovial tissues via suppressing the phosphorylation and degradation of IκB. 30831463 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE This case suggests that with exacerbation of arthritis during gouty arthritis, coexistence with other pathologies such as peripheral spondyloarthritis should be considered, and early intensive treatment including tumor necrosis factor inhibitors may be necessary. 31577714 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE Antidrug antibodies had no effect on the Assessment of Spondylosis Arthritis International Society (ASAS) remission rates, but patients with antidrug antibodies had lower drug levels and higher TNF-α levels. 30747393 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE Univariate analysis of arthritis CSF proteome revealed a decrease of 35 proteins, predominantly involved in inflammatory processes, following TNF blockade. 30770760 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE Addition of IL-17A, IL-17F and TNFα to synovial fibroblasts from patients with inflammatory arthritis resulted in significant production of IL-6 and IL-8, which was reduced to a larger extent by combined blockade of IL-17A and IL-17F than blockade of IL-17A alone. 31850514 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE These findings indicate that TNF selectively drives the early onset of arthritis and progression of pathologic changes in the cardiopulmonary system in female Tg3647 mice. 30969024 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE Our results showed GSZD reduced the toe swelling & arthritis score, and serum levels of TNF-α, IL-1β, IL-6 & IL-17a in CIA rats; pathological examination results indicated GSZD improved ankle joint injury in CIA rats.In vitro, GSZD showed significant anti-proliferative and pro-apoptotic effects on TNF-α stimulated MH7A cells. 31545276 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE Rats treated with UP1306 showed statistically significant improvements in arthritis severity markers, including uCTX-II (91.4% vs. collagen-induced arthritis (CIA)), serum IL-1β, TNF-α, and IL-6 levels as well as synovial MMP-13. 30691120 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE TNF-mediated inflammatory arthritis was significantly attenuated in the absence of functional RANKL. 30804932 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE Arthritis scores were calculated and serum levels of TNF-α were measured prior to and following treatment. 30783427 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice. 29375132 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE Here, we investigated the effect of TNF inhibition alone on spinal progression when used during arthritis development in a murine model. 31784598 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE GDF11 antagonizes TNF-α-induced inflammation and protects against the development of inflammatory arthritis in mice. 30407878 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE Recent findings showed elevated expression of tumor necrosis factor (TNF)-like ligand 1A (TL1A) in rheumatoid arthritis (RA) patients and arthritis mice. 30488533 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE Our study demonstrated for the first time that an early treatment with NSAIDs, excluding cyclooxygenase-2 selective inhibitor, is more beneficial than a TNFα blocker in preventing structural damage in adjuvant-induced arthritis. 30715482 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE In vitro and in vivo screening of an Food and Drug Administration (FDA)-approved drug library; in vitro and in vivo assays for examining the blockade of TNF actions by fexofenadine: assays for defining the anti-inflammatory activity of fexofenadine using TNF-α transgenic (TNF-tg) mice and collagen-induced arthritis in DBA/1 mice. 31302596 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 GeneticVariation disease BEFREE All the treated groups showed a significant therapeutic improvement in arthritis proved by measuring rats knee diameter as well as the tumor necrosis factor-alpha (TNF-α). 31351180 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE The TNF-transgenic (TNF-Tg) murine model of RA develops both inflammatory arthritis and an ILD that mimics a cellular nonspecific interstitial pneumonia pattern dominated by an interstitial accumulation of inflammatory cells with minimal-to-absent fibrosis. 31659014 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 Biomarker disease BEFREE Our findings indicate that combined neutralization of TNF-α and IL-17A was considerably more effective than monotherapy in improving collagen-induced arthritis disease even when administered at a minimally efficacious dose. 30745461 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.100 AlteredExpression disease BEFREE The arthritis/DSS-treated mice did not demonstrate changes in hind foot volumes or in the concentration of matrix metalloproteinase-3 (MMP-3) in the plasma; however, plasma levels of interleukin-6 (IL-6) and tumor necrosis factor (TNF)-α were increased. 31366877 2019